Having trouble accessing articles? Reset your cache.

China's top court invalidates Lipitor patent

China's Supreme People's Court ruled invalid a patent covering crystalline formulations of Lipitor atorvastatin from Pfizer Inc. (NYSE:PFE), preventing it

Read the full 207 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE